VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Grifols, S.A. (GRFS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - General · market value about $5.8B · P/E 10.5 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows